Norepinephrine Drug Market Trends

Growth Drivers

• Exceptional properties of norepinephrine drug
  Norepinephrine drug has some exceptional advantages over other alpha-adrenergic agonists, it is considered to have more predictive pharmaceutical properties. This predictive quality, combined with some of its beta-adrenergic agonist (which improves cardiac function comparative to pure alpha-adrenergic agonists), makes norepinephrine a widely used sympathomimetic drug. It is commonly used in intensive care units to treat hypotension. Additionally, it is the first-line agent for treating hypotension. This advantage is anticipated to provide lucrative business opportunities for norepinephrine drug market during the forecast period. 

• Surge in geriatric individuals to boost the norepinephrine drug market
  According to a 2017 UN report on World Population Ageing, the global population aged 60 years or over totalled 962 million in 2017, more than twice as large as in 1980 when there were 382 million older persons worldwide. The number of geriatric individuals is expected to double again by 2050 when it is projected to reach nearly 2.1 billion.
  
  Aged individuals are more prone to the risk of low blood pressure, and at present, the population of geriatric individuals in most of the developed economies along with developing nations is increasing at a significant rate. The risk of hypotension normally increases with age due to the decline in blood flow to the heart, muscle and the brain, which often result in the plaque build-up in blood vessels. Hence, the rise in geriatric population is estimated to contribute towards the market demand for norepinephrine drug in future.

Challenges

• Side Effects of Drug to Hamper the Market Growth
  Drugs are given to save patients from life-threatening conditions and are used to deliver viability to serious condition patients. Except that there are a few major side effects associated with the norepinephrine drug present in the norepinephrine drug market. These might consist of sudden numbness, weakness, uneven heart rate, blue lips or fingernails, mottled skin, trouble breathing, problem with speech, severe headache, blurred vision and others. Moreover, stopping the norepinephrine drug might lead to the recurrence of low blood pressure (hypotension). On account of these, the market for the norepinephrine drugs is estimated to observe limited growth in future.